Parkinson's Pathway Molecular Data Analysis
Event details
| Date | 28.09.2021 |
| Category | Call for proposal |
| Event Language | English |
Aim:
The Outcome Measures Parkinson's Pathway Molecular Data Analysis Program aims to identify and characterize novel biomarkers and critical pathways from existing molecular data sets. This funding opportunity is intended for applications using existing and novel computational, informatic, and data science strategies to interrogate molecular data sets relevant to Parkinson's disease.
Applications should focus on studies that achieve one or more of the following goals:
Deadline:
Eligibility: Applications may be submitted by researchers or clinicians in:
The Outcome Measures Parkinson's Pathway Molecular Data Analysis Program aims to identify and characterize novel biomarkers and critical pathways from existing molecular data sets. This funding opportunity is intended for applications using existing and novel computational, informatic, and data science strategies to interrogate molecular data sets relevant to Parkinson's disease.
Applications should focus on studies that achieve one or more of the following goals:
- Comparisons of analytes across complementary cohorts to identify or evaluate performance of putative biomarkers
- Evaluation of underexplored genetic variants associated with PD risk and correlates with clinical or molecular features of disease.
- Identification of novel molecular indicators of phenoconversion and/or PD subtyping.
- Integrated analysis of multi-omic data sets to identify and characterize critical pathways disrupted in Parkinson’s disease
- Identification of novel genotype-phenotype implications on molecular features of disease
- Characterization of molecular indicators of the role of the immune system in PD risk and patient outcomes.
- Identification or evaluation of molecular indicators of lysosomal and endosomal function, dysfunction, or functional diversity relevant to PD risk and penetrance
Deadline:
- Pre-proposals Due: September 28, 2021, 5 p.m. US ET
- Full Proposals Due (by invite only): January 13, 2022, 5 p.m. US ET
Eligibility: Applications may be submitted by researchers or clinicians in:
- U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
- U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
- Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research. The administrative co-PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Training or mentoring-only proposals will not be considered.
- Download the RFA overview and application template.
- Log in or create an account in the grant application portal.
- Submit your completed application.
- Email [email protected] with specific questions
- Contact the Research Office at [email protected] for general questions and if you decide to submit a proposal
Practical information
- General public
- Free
Organizer
- The Research Office